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Abstract
Hypoxia and acidity act as environmental stressors promoting selection for cancer cells
with a more aggressive phenotype. As a result, a deeper theoretical understanding of the
spatio-temporal processes that drive the adaptation of tumour cells to hypoxic and acidic mi-
croenvironments may open up new avenues of research in oncology and cancer treatment. We
present a mathematical model to study the influence of hypoxia and acidity on the evolution-
ary dynamics of cancer cells in vascularised tumours. The model is formulated as a system of
partial integro-differential equations that describe the phenotypic evolution of cancer cells in
response to dynamic variations in the spatial distribution of three abiotic factors that are key
players in tumour metabolism: oxygen, glucose and lactate. The results of numerical simula-
tions of a calibrated version of the model based on real data recapitulate the eco-evolutionary
spatial dynamics of tumour cells and their adaptation to hypoxic and acidic microenviron-
ments. Moreover, such results demonstrate how nonlinear interactions between tumour cells
and abiotic factors can lead to the formation of environmental gradients which select for cells
with phenotypic characteristics that vary with distance from intra-tumour blood vessels, thus
promoting the emergence of intra-tumour phenotypic heterogeneity. Finally, our theoretical
findings reconcile the conclusions of earlier studies by showing that the order in which re-
sistance to hypoxia and resistance to acidity arise in tumours depend on the ways in which
oxygen and lactate act as environmental stressors in the evolutionary dynamics of cancer cells.
Keywords: Mathematical oncology, Intra-tumour heterogeneity, Eco-evolutionary dynamics,
Vascularised tumours, Partial integro-differential equations
1 Introduction
Cancer is a dynamic disease, the characteristics of which are constantly evolving. This is reflected
in the fact that the genotypic and phenotypic properties of cancer cells may change across space
and time within the same tumour, and the dynamics of tumours with the same histological features
are still likely to vary across patients. Moreover, since the same cancer clones may arise through
different evolutionary pathways, the fact that two tumours have a similar clonal composition at
a given point in time does not necessarily indicate that they share similar evolutionary histories,
and does not rule out the possibility that their future evolution will diverge significantly [46].
These sources of variability within and between tumours provide the substrate for the emergence
and development of intra- and inter-tumour heterogeneity, which are major obstacles to cancer
eradication [29, 48].
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Clinical evidence suggests that cancer cells and the tumour microenvironment mutually shape
each other [24]. This supports the idea that tumours can be seen as evolving ecosystems where
cancer cells with different phenotypic characteristics proliferate, die, undergo genotypic and pheno-
typic changes, and compete for space and resources under the selective pressure exerted by the var-
ious components of the tumour microenvironment [23, 28, 32, 36, 39, 40, 50, 52, 62]. In this light,
intra-tumour phenotypic heterogeneity can be regarded as the outcome of an eco-evolutionary
process in which spatial variability of the concentration of abiotic factors (i.e. substrates and
metabolites) across the tumour supports the formation of distinct ecological niches whereby cells
with different phenotypic characteristics may be selected [14, 26, 31].
In normal tissues, cells produce the energy required to sustain their proliferation via oxidative
phosphorylation (i.e. they rely on oxygen as their primary source of energy) and turn to glycolysis
only when oxygen is scarce. In tumours, the presence of hypoxic regions (i.e. regions where the
oxygen levels are below the physiological ones) induces cells to transiently switch to a glycolytic
metabolic phenotype (i.e. to rely on glucose as their primary source of energy) [63]. Cancer cells
eventually acquire such a glycolytic phenotype and express it also in aerobic conditions, leading
to the so-called Warburg effect [33]. The interplay between the high glycolytic rate of cancer
cells and low perfusion in tumours brings about accumulation of lactate (i.e. a waste product of
glycolysis), which causes acidity levels in the tumour microenvironment to rise (i.e. the pH level
drops) [60].
Since hypoxia and acidity act as environmental stressors promoting selection for cancer cells
with a more aggressive phenotype [57, 60], an in-depth theoretical understanding of the spatio-
temporal processes that drive the adaptation of tumour cells to hypoxic and acidic microenviron-
ments may open up new avenues of research in oncology and cancer treatment [47]. In this regard,
mathematical models can be an important source of support to cancer research, as they enable
extrapolation beyond scenarios which can be investigated through experiments and may reveal
emergent phenomena that would otherwise remain unobserved [4, 13, 16, 17, 30]. For instance,
in their pioneering paper [25], Gatenby and Gawlinski used a reaction-diffusion system to explore
how nonlinear interactions between cancer cells and abiotic components of the tumour microen-
vironment may shape tumour growth. The Gatenby-Gawlinski model has recently been extended
in [58], in order to take into account the presence of cells with different phenotypic characteristics
within the tumour. Hybrid cellular automaton models have been employed to study the impact
of hypoxia and acidity on tumour growth and invasion [3, 5, 26, 34, 57]. A mechanical model of
tumour growth whereby cells are allowed to switch between aerobic and anaerobic metabolism
was presented in [9]. Integro-differential equations and partial integro-differential have been used
in [7, 15, 42, 44, 64] to investigate the ecological role of hypoxia in the development of intra-tumour
phenotypic heterogeneity.
In this paper, we complement these earlier studies by presenting a mathematical model to study
the influence of hypoxia and acidity on the evolutionary dynamics of cancer cells in vascularised
tumours. The model comprises a system of partial integro-differential equations that describe the
phenotypic evolution of cancer cells in response to dynamic variations in the spatial distribution
of three abiotic factors that are key players in tumour metabolism: oxygen, glucose and lactate.
The remainder of the paper is organised as follows. In Section 2, we present the model equa-
tions and the underlying modelling assumptions. In Section 3, we summarise the main results of
numerical simulations of the model and discuss their biological implications. Section 4 concludes
the paper and provides a brief overview of possible research perspectives.
2 Model description
We consider a one-dimensional region of vascularised tissue of length L > 0. We describe the
spatial position of every tumour cell in the tissue region by a scalar variable x ∈ [0,L] and we
assume a blood vessel to be present at x = 0 (cf. the schematic in Figure 1a). Moreover, building
upon the modelling framework developed in [15, 42, 44, 64], we model the phenotypic state of
every cell by a vector y = (y1, y2) ∈ [0, 1]2 (cf. the schematics in Figure 1b). Here, y1 ∈ [0, 1]
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represents the normalised level of expression of an acidity-resistant gene (e.g. the LAMP2 gene),
while y2 ∈ [0, 1] represents the normalised level of expression of a hypoxia-resistant gene (e.g. the
GLUT-1 gene) [19, 26].
We describe the phenotypic distribution of tumour cells at position x and time t ∈ [0,T], with
T > 0, by means of the local population density function n(t, x,y) (i.e. the local phenotypic
distribution of tumour cells). We define the cell density ρ(t, x), the local mean level of expression
of the acidity-resistant gene µ1(t, x) and the local mean level of expression of the hypoxia-resistant
gene µ2(t, x) as
ρ(t, x) :=
∫
[0,1]2
n(t, x,y) dy, µi(t, x) :=
1
ρ(t, x)
∫
[0,1]2
yi n(t, x,y) dy (1)
for i = 1, 2. Moreover, we define the phenotypic distribution of tumour cells across the whole
tissue region f(t,y) as the mean value of n(t, x,y) on the interval [0,L], i.e.
f(t,y) :=
1
L
∫ L
0
n(t, x,y) dx. (2)
Similarly, we define the levels of expression of the acidity-resistant gene and the hypoxia-resistant
gene across the whole tissue region as the mean values of µ1(t, x) and µ2(t, x) on the interval [0,L],
respectively, i.e.
ν1(t) :=
1
L
∫ L
0
µ1(t, x) dx and ν2(t) :=
1
L
∫ L
0
µ2(t, x) dx. (3)
The local concentrations of oxygen, glucose and lactate at position x and time t are denoted
by So(t, x), Sg(t, x) and Sl(t, x), respectively.
Figure 1: a) Schematic of the spatial domain defined as a one-dimensional region of vascularised tissue of length
L. A blood vessel is assumed to be present at x = 0. b) Schematics illustrating the relationships between the values
of the variables y2 and y1 modelling the phenotypic state of tumour cells and the levels of resistance to hypoxia
and acidosis.
2.1 Dynamics of tumour cells
We describe the dynamics of tumour cells through the following balance equation for the local
population density function n(t, x,y)
∂n
∂t
= βn
∂2n
∂x2︸ ︷︷ ︸
undirected, random
cell movement
+ θ∆yn︸ ︷︷ ︸
spontaneous
phenotypic changes
+ R (So, Sg, Sl, ρ,y)n︸ ︷︷ ︸
proliferation and death
, (4)
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with (t, x,y) ∈ (0,T]× (0,L)× (0, 1)2, subject to suitable initial conditions. We complement (4)
with zero-flux boundary conditions at x = 0 and x = L (i.e. we assume that cells cannot leave
the tissue region) and zero-flux boundary conditions on the boundary of the square [0, 1]2 (i.e. we
assume that cells cannot have normalised levels of gene expression smaller than 0 or larger than
1).
The first term on the right-hand side of the partial integro-differential equation (4) models the
effect of undirected, random movement, which is described through Fick’s first law of diffusion with
diffusivity βn > 0, while the second term models the effect of heritable, spontaneous phenotypic
changes, which occur at rate θ > 0. The function R(So, Sg, Sl, ρ,y) represents the fitness of tumour
cells in the phenotypic state y at position x and time t under the environmental conditions given
by the concentrations of abiotic factors So(t, x), Sg(t, x) and Sl(t, x), and the cell density ρ(t, x)
(i.e. R(So, Sg, Sl, ρ,y) is the phenotypic fitness landscape of the tumour). We use the following
definition
R(So, Sg, Sl, ρ,y) := P (So, Sg, y2)︸ ︷︷ ︸
proliferation and
death due to
oxygen-driven selection
− D(Sl, y1)︸ ︷︷ ︸
death due to
lactate-driven selection
− d(ρ).︸ ︷︷ ︸
death due to
competition
for space
(5)
Here, the function P (So, Sg, y2) is the rate at which cells with level of expression y2 of the hypoxia-
resistant gene proliferate via oxidative phosphorylation and glycolysis, and die due to oxygen-
driven selection (i.e. P (So, Sg, y2) is a net proliferation rate). The function D(Sl, y1) is the rate
at which cells with level of expression y1 of the acidity-resistant gene die due to lactate-driven
selection. The function d(ρ) models the rate of cell death due to competition for space associated
with saturation of the cell density.
2.1.1 Modelling oxygen-driven selection
Based on the theoretical results and experimental data presented in [36, 63], we focus on a scenario
corresponding to the following biological assumptions.
Assumption 1. There exist two threshold levels of the oxygen concentration OM > Om > 0
such that the environment surrounding the cells is: hypoxic if So ≤ Om; moderately oxygenated if
Om < So < OM ; normoxic (i.e. well oxygenated) if So ≥ OM .
Assumption 2. Cells proliferate at a rate that depends on the concentrations of oxygen and
glucose. Moreover, the trade-off between increase in cell death associated with sensitivity to hypoxia
and decrease in cell proliferation associated with acquisition of resistance to hypoxia results in the
existence of a level of expression of the hypoxia-resistant gene which is the fittest in that: a lower
level of gene expression would correlate with a lower resistance to hypoxia, and thus a higher death
rate; a higher level of gene expression would correlate with a larger fitness cost, and thus a lower
proliferation rate. Cells with levels of gene expression that are closer to the fittest one are more
likely to survive than the others. Hence, the farther the gene expression level of a cell is from the
fittest one, the more likely is that the cell will die due to a form of oxygen-driven selection.
Assumption 3. In normoxic environments (i.e. when So ≥ OM ), the energy required for cell pro-
liferation is produced via oxidative phosphorylation and the cell proliferation rate is a monotonically
increasing function of the concentration of oxygen. In hypoxic environments (i.e. when So ≤ Om),
the energy required for cell proliferation is produced via glycolysis and the cell proliferation rate
is a monotonically increasing function of the concentration of glucose. In moderately-oxygenated
environments (i.e. when Om < So < OM ), the energy required for cell proliferation is produced
via both oxidative phosphorylation and glycolysis. Moreover, the cell proliferation rate is a mono-
tonically increasing function of the concentrations of oxygen and glucose, and lower values of the
oxygen concentration correlate with a greater tendency of the cells to proliferate via glycolysis.
Assumption 4. The fittest level of expression of the hypoxia-resistant gene (i.e. the gene asso-
ciated with the variable y2) may vary with the oxygen concentration. In particular: in normoxic
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environments (i.e. when So ≥ OM ), the fittest level of gene expression is the minimal one (i.e.
y2 = 0); in hypoxic environments (i.e. when So ≤ Om) the fittest level of gene expression is the
maximal one (i.e. y2 = 1); in moderately-oxygenated environments (i.e. when Om < So < OM ),
the fittest level of gene expression is a monotonically decreasing function of the oxygen concentra-
tion (i.e. it decreases from y2 = 1 to y2 = 0 when the oxygen concentration increases).
Under Assumptions 1 and 2, we define the net proliferation rate P (So, Sg, y2) as
P (So, Sg, y2) := po(So)︸ ︷︷ ︸
proliferation via
oxidative phosphorylation
+ pg(So, Sg)︸ ︷︷ ︸
proliferation via
glycolysis
− ηo
(
y2 − ϕo(So)
)2︸ ︷︷ ︸
death due to
oxygen-driven selection
. (6)
In (6), the function po(So) models the rate of cell proliferation via oxidative phosphorylation, while
the function pg(So, Sg) models the rate of cell proliferation via glycolysis. Furthermore, the third
term in the definition given by (6) is the rate of death induced by oxygen-driven selection. Here,
the parameter ηo > 0 is a selection gradient that quantifies the intensity of oxygen-driven selection
and the function ϕo(So) is the fittest level of expression of the hypoxia-resistant gene under the
environmental conditions given by the oxygen concentration So.
Remark 1. In (6), the distance between y2 and ϕo(So) is computed as
(
y2 − ϕo(So)
)2
. Alterna-
tively, one could compute such a distance as
∣∣y2−ϕo(So)∣∣. However, we have chosen (y2−ϕo(So))2
over
∣∣y2 −ϕo(So)∣∣ because, as discussed in [7, 41], it leads to a smoother fitness function which is
closer to the approximate fitness landscapes which can be inferred from experimental data through
regression techniques.
Under Assumptions 3 and 4, we use the definitions of the functions po(So), pg(So, Sg) and
ϕo(So) given hereafter
po(So) :=
γo So
αo + So
w(So), pg(So, Sg) :=
γg Sg
αg + Sg
(
1− w(So)
)
, (7)
with
w(So) :=

1 So ≥ OM
1− OM − So
OM −Om Om < So < OM
0 So ≤ Om
(8)
and
ϕo(So) :=

0 So ≥ OM
OM − So
OM −Om Om < So < OM
1 So ≤ Om.
(9)
In (7), the parameters γo > 0 and γg > 0 model the maximum rates of cell proliferation via
oxidative phosphorylation and glycolysis, respectively. The parameters αo > 0 and αg > 0 are
the Michaelis-Menten constants of oxygen and glucose. The weight function w(So) defined via (8)
ensures that Assumption 3 is satisfied, while definition (9) of ϕo(So) is such that Assumption 4 is
satisfied (cf. the plot in Figure 2a).
2.1.2 Modelling lactate-driven selection
Based on theoretical results and experimental data presented in [57], we focus on a scenario
corresponding to the following biological assumptions.
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Assumption 5. There exist two threshold levels of the lactate concentration LM > Lm > 0 such
that the environment surrounding the cells is: mildly acidic if Sl ≤ Lm; moderately acidic if
Lm < Sl < LM ; highly acidic if Sl ≥ LM .
Assumption 6. Cells die at a rate that depends on the concentration of lactate. Moreover, the
trade-off between increase in cell death associated with sensitivity to acidity and decrease in cell
proliferation associated with acquisition of resistance to acidity results in the existence of a level of
expression of the acidity-resistant gene which is the fittest in that: a lower level of gene expression
would correlate with a lower resistance to acidity, and thus a higher death rate; a higher level of
gene expression would correlate with a larger fitness cost, and thus a lower proliferation rate. Cells
with levels of gene expression that are closer to the fittest one are more likely to survive than the
others. Hence, the farther the gene expression level of a cell is from the fittest one, the more likely
is that the cell will die due to a form of lactate-driven selection.
Assumption 7. The fittest level of expression of the acidity-resistant gene (i.e. the gene associated
with the variable y1) may vary with the lactate concentration. In particular: in mildly-acidic
environments (i.e. when Sl ≤ Lm), the fittest level of gene expression is the minimal one (i.e.
y1 = 0); in highly-acidic environments (i.e. when Sl ≥ LM ) the fittest level of gene expression is
the maximal one (i.e. y1 = 1); in moderately-acidic environments (i.e. when Lm < Sl < LM ), the
fittest level of gene expression is a monotonically increasing function of the lactate concentration
(i.e. it increases from y1 = 0 to y1 = 1 when the lactate concentration increases).
Under Assumptions 5 and 6, we define the rate of cell death due to lactate-driven selection
D(Sl, y1) as
D(Sl, y1) := ηl
(
y1 − ϕl(Sl)
)2
. (10)
In (10), the parameter ηl > 0 is a selection gradient that quantifies the intensity of lactate-driven
selection and the function ϕl(Sl) is the fittest level of expression of the acidity-resistant gene under
the environmental conditions given by the lactate concentration Sl. Considerations analogous to
those made in Remark 1 on the term
(
y2−ϕo(So)
)2
in (6) apply to the term
(
y1−ϕl(Sl)
)2
in (10).
Finally, we use the definition of the function ϕl(Sl) given hereafter (cf. the plot in Figure 2b), so
that Assumption 7 is satisfied:
ϕl(Sl) :=

0 Sl ≤ Lm
Sl − Lm
LM − Lm Lm < Sl < LM
1 Sl ≥ LM .
(11)
2.1.3 Modelling competition for space
We define the rate of cell death due to competition for space associated with saturation of the cell
density as
d(ρ) := κ ρ. (12)
Here, the proportionality constant κ > 0 is related to the local carrying capacity of the tumour,
which may vary depending on the tumour type.
2.2 Dynamics of abiotic factors
Oxygen and glucose are consumed by tumour cells, while lactate is produced by tumour cells as a
waste product of glycolysis. Moreover, oxygen, glucose and lactate diffuse in space and decay over
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Figure 2: a) Plot of the fittest level of expression of the hypoxia-resistant gene ϕo(So) defined via (9). The vertical,
dashed lines highlight the oxygen levels Om and OM . Hence, the white region corresponds to normoxic conditions,
the pale-blue region corresponds to moderately-oxygenated environments and the blue region corresponds to hypoxic
conditions. b) Plot of the fittest level of expression of the acidity-resistant gene ϕl(Sl) defined via (11). The
vertical, dashed lines highlight the lactate levels Lm and LM . Hence, the white region corresponds to mildly-acidic
conditions, the pale-green region corresponds to moderately-acidic conditions and the green region corresponds to
highly-acidic conditions.
time. Hence, their dynamics are governed by the following balance equations for the functions
So(t, x), Sg(t, x) and Sl(t, x), respectively,
∂So
∂t
= βo
∂2So
∂x2︸ ︷︷ ︸
diffusion
− λo So︸ ︷︷ ︸
natural
decay
− ζo po(So) ρ,︸ ︷︷ ︸
consumption by tumour cells
(13)
∂Sg
∂t
= βg
∂2Sg
∂x2︸ ︷︷ ︸
diffusion
− λg Sg︸ ︷︷ ︸
natural
decay
− ζg pg(So, Sg) ρ︸ ︷︷ ︸
consumption by tumour cells
(14)
and
∂Sl
∂t
= βl
∂2Sl
∂x2︸ ︷︷ ︸
diffusion
− λl Sl︸︷︷︸
natural
decay
+ ζl pg(So, Sg) ρ,︸ ︷︷ ︸
production by tumour cells
(15)
with (t, x) ∈ (0,T]×(0,L), subject to suitable boundary conditions (see considerations below) and
initial conditions.
In (13)-(15), the parameters βo > 0, βg > 0 and βl > 0 are the diffusion coefficients of oxygen,
glucose and lactate, respectively, while the parameters λo > 0, λg > 0 and λl > 0 are the natural
decay rates of the three abiotic factors. The third term on the right-hand side of (13) is the
consumption rate of oxygen by tumour cells, which is proportional to the product between the cell
density ρ and the rate of cell proliferation via oxidative phosphorylation po(So), which is defined
via (7). The parameter ζo > 0 is a conversion factor linked to oxygen consumption by the cells.
Analogous considerations hold for the third term on the right-hand side of (14), which models the
consumption rate of glucose by tumour cells. Furthermore, the third term on the right-hand side
of (15) is the production rate of lactate by tumour cells, which is assumed to be proportional to
the product between the cell density ρ and the rate of cell proliferation via glycolysis pg(So, Sg)
defined via (7). The constant of proportionality is the conversion factor ζl > 0 linked to lactate
production by the cells.
We assume that oxygen and glucose enter the spatial domain through the blood vessel only,
while lactate is flushed out through the blood vessel only. Hence, focussing on the case where the
inflow rate of oxygen and glucose and the outflow rate of lactate are constant, we complement (13)-
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(15) with the following boundary conditions at x = 0
So(t, 0) = So, Sg(t, 0) = Sg, Sl(t, 0) = Sl for all t > 0, (16)
where So > 0 and Sg > 0 are related to the average physiological levels of oxygen and glucose in
proximity to blood vessels, while Sl > 0 is a small parameter of value close to zero. In particular,
we have So > OM and Sl < Lm. Moreover, we assume that far from the blood vessel the
concentrations of oxygen and glucose drop to some lower values 0 < So < So and 0 < Sg < Sg,
which correspond to the levels of oxygen and glucose which are typically observed in regions
distant from blood vessels. In particular, we have So < Om. Furthermore, we model abnormal
accumulation of lactate, which is expected to occur far from blood vessels, imposing zero-flux
boundary conditions. Therefore, we complement (13)-(15) with the following boundary conditions
at x = L
So(t,L) = So, Sg(t,L) = Sg,
∂Sl(t,L)
∂x
= 0 for all t > 0. (17)
3 Main results
In this section, we present the results of numerical simulations of the mathematical model defined
by (4) coupled with (13)-(15) and we discuss their biological relevance. First, we describe the set-
up of numerical simulations (see Section 3.1). Next, we present a sample of numerical solutions
that summarise the spatial dynamics of tumour cells and abiotic factors (see Section 3.2). Then,
we report on the results of numerical simulations showing the evolutionary dynamics of tumour
cells and the emergence of phenotypic heterogeneity (see Section 3.3). Finally, we present the
results of numerical simulations that reveal the existence of alternative evolutionary pathways
that may lead to the development of resistance to hypoxia and acidity in vascularised tumours
(see Section 3.4).
3.1 Set-up of numerical simulations
Numerical simulations are carried out assuming L = 400µm, which is chosen coherently with
experimental data reported in [54], and t ∈ [0,T], where the final time T > 0 is such that the
solutions of the model equations are at numerical equilibrium for t = T.
Initial conditions. We consider (13), (14) and (15) subject, respectively, to the following initial
conditions
So(0, x) = S
0
o(x), Sg(0, x) = S
0
g(x) and Sl(0, x) = S
0
l (x) ≡ Sl. (18)
Here, the functions S0o(x) and S
0
g(x) (see Figure 3) are defined in such a way as to match the
experimental equilibrium distributions of oxygen and glucose presented in [54, Fig. 2], while
Sl is the same small parameter used in (16), i.e. Sl < Lm. Initial conditions (18) correspond
to a situation in which the initial distributions of oxygen and glucose match with experimental
equilibrium distributions of such abiotic factors and lactate is present at a uniform level which is
below the threshold level Lm, that is, the level below which the environment surrounding the cells
is mildly acidic and the fittest level of expression of the acidity-resistant gene is the minimal one.
Moreover, we complement (4) with the following initial condition
n(0, x,y) = n0(x,y) := 200 exp
(
− (x− 0)
2
0.0002
− |y − 0|
2
0.4
)
, (19)
which corresponds to a biological scenario in which at the initial time t = 0 most tumour cells are
concentrated near the blood vessel and are characterised by the minimal expression level of both
the hypoxia-resistant gene and the acidity-resistant gene.
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Boundary conditions. We use the following values of the parameters So, Sg and Sl in (16)
So = 2.08× 10−6 g/cm3, Sg = 1.35× 10−4 g/cm3, Sl = 10−8 g/cm3 (20)
and the following values of the parameters So and Sg in (17)
So = 2× 10−10 g/cm3, Sg = 1.35× 10−6 g/cm3. (21)
The values of So and Sg correspond to the average physiological levels of oxygen and glucose in
proximity to blood vessels reported in [54]. Moreover, the values of So and Sg correspond to the
0.1% of So and the 1% of Sg, respectively. This is because, based on experimental data reported
in [54], we expect the concentrations of oxygen and glucose at 400µm from the blood vessel (i.e.
at x = L) to drop, respectively, below the 0.1% and the 1% of their value near the blood vessel.
Figure 3: Plots of the initial distribution of oxygen S0o(x) (blue curve, axis on the left) and the initial distribution
of glucose S0g(x) (red curve, axis on the right) which are defined in such a way as to match the experimental
equilibrium distributions of oxygen and glucose presented in [54, Fig. 2]. The vertical, dashed lines highlight the
points xOM and xOm such that S
0
o(xOM ) = OM and S
0
o(xOm ) = Om. Hence, the white region corresponds to
normoxic conditions, the pale-blue region corresponds to moderately-oxygenated environments and the blue region
corresponds to hypoxic conditions.
Parameter values. Unless otherwise explicitly stated, we use the values of the model parame-
ters listed in Table 1, which are chosen to be consistent with the existing literature, except for the
values of the parameters ηo, ηl, λl and ζl that are model specific in that we could not find them
in the literature and are defined on the basis of the following considerations. The value of the
conversion factor for lactate production ζl is chosen to be the same as the value of the conversion
factor for glucose consumption ζg. Furthermore, the value of the rate of natural decay of lactate
λl is such that the distribution of lactate at numerical equilibrium (i.e. the graph of Sl(T, x)) is
similar to the lactate distributions reported in [54]. Finally, the values of the selection gradients ηo
and ηl are chosen with exploratory aim and a systematic sensitivity analysis of these parameters
is performed in Section 3.4.
Numerical methods. Numerical solutions are constructed using a uniform discretisation of
the interval [0,L] as the computational domain of the independent variable x and a uniform
discretisation of the square [0, 1]2 as the computational domain of the independent variable y.
We also discretise the interval [0,T] with a uniform step. The method for constructing numerical
solutions is based on an explicit finite difference scheme in which a three-point and a five-point
stencils are used to approximate the diffusion terms in x and y, respectively, and an implicit-
explicit finite difference scheme is used for the reaction terms [37, 45]. All numerical computations
are performed in Matlab.
9
Table 1: Parameter values used in numerical simulations.
Par. Biological meaning Value Units Ref.
βo Diffusion coefficient of oxygen 1.46 × 10−5 cm2s−1 [54]
βg Diffusion coefficient of glucose 1.10 × 10−6 cm2s−1 [54]
βl Diffusion coefficient of lactate 1.9 × 10−6 cm2s−1 [54]
βn Cell motility 10−13 cm2s−1 [64]
θ Rate of phenotypic changes 10−13 s−1 [64]
λo Rate of natural decay of oxygen 1.2 × 10−3 s−1 [54]
λg Rate of natural decay of glucose 2.33 × 10−5 s−1 [54]
λl Rate of natural decay of lactate 5 × 10−2 s−1 ad hoc
γo Max. prolif. rate via oxidative phosphorylation 3.65 × 10−7 s−1 [54]
αo Michaelis-Menten constant of oxygen 6.4 × 10−9 g cm−3 [54]
γg Max. prolif. rate via glycolysis 3.42 × 10−7 s−1 [54]
αg Michaelis-Menten constant of glucose 9 × 10−6 g cm−3 [54]
ηo Selection gradient related to oxygen 3.65 × 10−2 s−1 ad hoc
ηl Selection gradient related to lactate 10
−2 s−1 ad hoc
κ Rate of cell death due to competition for space 2 × 10−10 cm3s−1cells−1 [42]
ζo Conversion factor for oxygen consumption 10−8 g cells−1 [42]
ζg Conversion factor for glucose consumption 10−8 g cells−1 [42]
ζl Conversion factor for lactate production 10
−8 g cells−1 ad hoc
Om Threshold level of oxygen for hypoxic env. 8.2 × 10−9 g cm−3 [63]
OM Threshold level of oxygen for normoxic env. 4.3 × 10−7 g cm−3 [63]
Lm Threshold level of lactate for mildly-acidic env. 2 × 10−5 g cm−3 [57]
LM Threshold level of lactate for highly-acidic env. 7.15 × 10−5 g cm−3 [57]
L Max. distance from blood vessel 400 µm [54]
3.2 Dynamics of the cell density and the concentrations of abiotic fac-
tors
The dynamics of the density of tumour cells and the concentrations of abiotic factors are illustrated
by the plots in Figure 4. In summary, the cell density and the concentration of lactate at successive
times (i.e. the graphs of ρ(t, x) for four different values of t and Sl(t, x) for three different values
of t) are displayed in Figure 4a and Figure 4c, respectively, while the concentrations of oxygen
and glucose at time T (i.e. the graphs of So(T, x) and Sg(T, x)) are displayed in Figure 4b.
The curves in Figure 4a show that cell movement in concert with cell proliferation and death
leads tumour cells, which are initially concentrated near the blood vessel at x = 0 (cf. the initial
condition n0(x,y) defined via (19)), to spread into the surrounding tissue (i.e. ρ(t, x) behaves like
an invasion front). At every position, the cell density grows until a saturation value, which varies
with the distance from the blood vessel, is reached (i.e. ρ(t, x) appears to converge to a form of
generalised transition wave [10, 11]). Moreover, the curves in Figure 4b show that the reaction-
diffusion dynamics of oxygen and glucose, along with the inflow through the blood vessel and the
consumption by tumour cells, lead the concentrations of such abiotic factors to converge to some
stable values which decrease as the distance from the blood vessel increases (i.e. at t = T, So(t, x)
and Sg(t, x) appear to be at numerical equilibrium and are monotonically decreasing functions
of x). Furthermore, the curves in Figure 4c show that the interplay of production by tumour
cells, outflow through the blood vessel and reaction-diffusion dynamics leads the concentration of
lactate to grow at every position until a saturation value, which varies with the distance from the
blood vessel, is reached (cf. the graph of Sl(T, x)).
Notice that the distributions of oxygen and glucose at the final time T are close to the initial
distributions S0o(x) and S
0
g(x) displayed in Figure 3. This is to be expected. In fact, since S
0
o(x) and
S0g(x) are defined in such a way as to match experimental equilibrium distributions of oxygen and
glucose, under the biologically informed parameter values (cf. Table 1) and boundary conditions
(cf. (16), (17) and (20), (21)) used here, the concentrations So(t, x) and Sg(t, x) reach quickly
numerical equilibrium. We verified via additional numerical simulations (results not shown) that,
as one would expect, the concentrations of oxygen and glucose at numerical equilibrium do not
depend on the choice of the initial conditions.
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The dashed lines in Figure 4 highlight the spatial positions xOM and xOm at which the
oxygen concentration at time T crosses, respectively, the threshold values OM and Om (i.e.
So(T, xOM ) = OM and So(T, xOm) = Om). Hence, the white region (i.e. the interval [0, xOM ]), the
pale-blue region (i.e. the interval (xOM , xOm)) and the blue region (i.e. the interval [xOm ,L]) cor-
respond to normoxic, moderately-oxygenated and hypoxic environmental conditions, respectively.
Under normoxic conditions (white regions), cells proliferate via oxidative phosphorylation at rate
γo So
αo + So
, while cell proliferation occurs via glycolysis at rate
γg Sg
αg + Sg
in hypoxic conditions (blue
regions). Moreover, in moderately-oxygenated environments (pale-blue regions), cells proliferate
via oxidative phosphorylation at rate
γo So
αo + So
w(So) and via glycolysis at rate
γg Sg
αg + Sg
(
1−w(So)
)
,
where w(So) decreases from 1 to 0 when So decreases from OM to Om (cf. the definition of w(So)
given by (8)). Coherently with experimental evidence indicating that using glycolysis to produce
energy required for cell proliferation is less efficient than employing oxidative phosphorylation, the
biologically informed parameter values considered here are such that the cell proliferation rate in
normoxic conditions is higher than the cell proliferation rate in moderately-oxygenated environ-
ments, which in turn is higher than the cell proliferation rate in hypoxic conditions (cf. the plot
in Figure 5, blue curve). As a result, the saturation value of the cell density decreases with the
distance from the blood vessel (i.e. ρ(T, x) is a monotonically decreasing function of x). Further-
more, the production rate of lactate by tumour cells is proportional to the rate of proliferation via
glycolysis and, therefore, it increases with the distance from the blood vessel at x = 0 (cf. the plot
in Figure 5, red curve). As a result, the saturation value of the lactate concentration increases
with the distance from the blood vessel and, in agreement with the lactate distributions reported
in [54], Sl(T, x) is a monotonically increasing function of x.
Figure 4: a) Plots of the cell density ρ(t, x) at four successive time instants (yellow, orange, red and burgundy
lines). The burgundy line highlights ρ(T, x). b) Plots of the concentrations of oxygen So(T, x) (blue line) and
glucose Sg(T, x) (red line). c) Plots of the concentration of lactate Sl(t, x) at three successive time instants (light-
green, green and dark-green lines). The dark-green line highlights Sl(T, x). In every panel, the vertical, dashed lines
highlight the points xOM and xOm such that So(T, xOM ) = OM and So(T, xOm ) = Om. Hence, the white region
corresponds to normoxic conditions, the pale-blue region corresponds to moderately-oxygenated environments and
the blue region corresponds to hypoxic conditions.
3.3 Evolutionary dynamics of tumour cells and emergence of phenotypic
heterogeneity
As discussed in the previous section, reaction-diffusion dynamics of abiotic factors and mutual
interactions between abiotic factors and tumour cells lead to the emergence of spatial variations in
the concentrations of oxygen and lactate – i.e. the oxygen concentration So(T, x) is a monotoni-
cally decreasing function of x while the lactate concentration Sl(T, x) is a monotonically increasing
function of x (cf. plots in Figure 4b and Figure 4c). Spatial variability of oxygen and lactate con-
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Figure 5: Plots of the cell proliferation rate po(So(T, x)) + pg(So(T, x), Sg(T, x)) (blue curve, axis on the left)
and the production rate of lactate ζl pg(So(T, x), Sg(T, x)) ρ(T, x) (red curve, axis on the right) defined via (7).
The vertical, dashed lines highlight the points xOM and xOm such that So(T, xOM ) = OM and So(T, xOm ) = Om.
Hence, the white region corresponds to normoxic conditions, the pale-blue region corresponds to moderately-
oxygenated environments and the blue region corresponds to hypoxic conditions.
centrations can lead to the formation of environmental gradients resulting in the selection for cells
with phenotypic characteristics that vary with distance from the blood vessel, thus promoting
the emergence of intra-tumour phenotypic heterogeneity. This is demonstrated by the numerical
results in Figure 6.
The dashed lines in Figure 6a and Figure 6b highlight the fittest levels of expression of the
hypoxia-resistant gene (see Figure 6a) and the acidity-resistant gene (see Figure 6b) at time T
[i.e. the graphs of ϕo(So(T, x)) and ϕl(Sl(T, x))], while the solid lines display the local mean
levels of expression of the hypoxia-resistant gene (see Figure 6a) and the acidity-resistant gene
(see Figure 6b) at four successive times (i.e. the graphs of µ2(t, x) and µ1(t, x) for four different
values of t). In analogy with Figure 4, the vertical, dashed lines in Figure 6a highlight the spatial
positions xOM and xOm at which the oxygen concentration at time T crosses, respectively, the
threshold values OM and Om (i.e. So(T, xOM ) = OM and So(T, xOm) = Om). Hence, the
white region corresponds to normoxic conditions, the pale-blue region corresponds to moderately-
oxygenated environments and the blue region corresponds to hypoxic conditions. Moreover, the
vertical, dashed lines in Figure 6b highlight the spatial positions xLm and xLM at which the lactate
concentration at time T crosses, respectively, the threshold values Lm and LM (i.e. Sl(T, xLm) =
Lm and Sl(T, xLM ) = LM ). Hence, the white region corresponds to mildly-acidic conditions, the
pale-green region corresponds to moderately-acidic conditions and the green region corresponds
to highly-acidic conditions.
As shown by the plots in Figure 6a and Figure 6b, the local mean levels of expression of the
hypoxia- and acidity-resistant genes converge, as time passes, to the fittest ones (i.e. µ2(T, x)
matches with ϕo(So(T, x)) and µ1(T, x) matches with ϕl(Sl(T, x)), the values of which vary with
the distance from the blood vessel depending on the local concentrations of oxygen and lactate.
In more detail, the local mean level of expression of the hypoxia-resistant gene at time T is
the minimal one in normoxic conditions (i.e. µ2(T, x) ≡ 0 for x ∈ [0, xOM ]), the maximal one in
hypoxic conditions (i.e. µ2(T, x) ≡ 1 for x ∈ [xOm ,L]) and increases with the oxygen concentration
in moderately-oxygenated environments (i.e. µ2(T, x) increases monotonically from 0 to 1 for
x ∈ (xOM , xOm)). Furthermore, the local mean level of expression of the acidity-resistant gene
at time T is the minimal one in the mildly-acidic region (i.e. µ1(T, x) ≡ 0 for x ∈ [0, xLm ]), the
maximal one in highly-acidic conditions (i.e. µ1(T, x) ≡ 1 for x ∈ [xLM ,L]) and increases with
the lactate concentration in moderately-acidic environments (i.e. µ1(T, x) increases monotonically
from 0 to 1 for x ∈ (xLm , xLM )).
Finally, the plots in Figures 6c-e show that, at every position x ∈ [0,L], the local phenotypic
distribution of tumour cells at time T (i.e. the local population density function n(T, x,y)) is
unimodal and attains its maximum at the fittest phenotypic state y =
(
ϕo(So(T, x)), ϕl(Sl(T, x)
)
.
The numerical results of Figure 6 are complemented by the numerical results displayed in Figure 7,
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which summarise the time-evolution of the phenotypic distribution of tumour cells across the whole
tissue region (i.e. the function f(t,y) defined via (2)) and show that the maximum point of the
distribution departs from the point y = (0, 0) (i.e. the point corresponding to the minimal
expression level of both the acidity-resistant gene and the hypoxia-resistant gene) – cf. the initial
condition n0(x,y) defined via (19) – and moves toward the point y = (1, 1), which corresponds
to the maximal expression level of both the hypoxia-resistant gene and the acidity-resistant gene
(i.e. the degree of malignancy of the tumour increases over time).
Figure 6: a) Plots of the normalised level of expression of the hypoxia-resistant gene µ2(t, x) at four successive
time instants (yellow, orange, red and light-green lines). The light-green line highlights µ2(T, x) and the burgundy,
dashed line highlights the fittest level of expression of the hypoxia-resistant gene ϕo(So(T, x)) defined via (9). The
vertical, dashed lines highlight the points xOM and xOm such that So(T, xOM ) = OM and So(T, xOm ) = Om.
Hence, the white region corresponds to normoxic conditions, the pale-blue region corresponds to moderately-
oxygenated environments and the blue region corresponds to hypoxic conditions. b) Plots of the normalised level
of expression of the acidity-resistant gene µ1(t, x) at four successive time instants (yellow, orange, red and light-blue
lines). The light-blue line highlights µ1(T, x) and the burgundy, dashed line highlights the fittest level of expression
of the acidity-resistant gene ϕl(Sl(T, x)) defined via (11). The vertical, dashed lines highlight the points xLm and
xLM such that Sl(T, xLm ) = Lm and Sl(T, xLM ) = LM . Hence, the white region corresponds to mildly-acidic
conditions, the pale-green region corresponds to moderately-acidic conditions and the green region corresponds to
highly-acidic conditions. c) - e) Plots of the local phenotypic distribution of tumour cells n(T, x,y) at the points
x = xa, x = xb and x = xc highlighted, respectively, by the circle, square and triangle markers shown in panels a)
and b).
3.4 Alternative evolutionary pathways leading to the development of
resistance to hypoxia and acidity
As discussed in the previous section, the degree of malignancy of the tumour increases over time
and the majority of cancer cells are ultimately characterised by high levels of expression of the
hypoxia-resistant gene and the acidity-resistant gene. Furthermore, the results we report on in
this section indicate that the dynamics of the levels of expression of the acidity-resistant gene and
the hypoxia-resistant gene across the whole tissue region (i.e. the functions ν1(t) and ν2(t) defined
via (3)) are strongly affected by the values of the selection gradient related to oxygen ηo and the
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Figure 7: Plots of the phenotypic distribution of tumour cells across the whole tissue region f(t,y) defined
according to (2) at six successive time instants t1 < t2 < . . . < t6.
selection gradient related to lactate ηl. In fact, as demonstrated by the plot in Figure 8, which
displays the curve φ(t) =
(
ν1(t), ν2(t)
)
for different values of the ratio ηo/ηl, depending on the
values of ratio between these parameters one has that resistance to hypoxia and resistance to acidity
arise via alternative evolutionary pathways. Coherently with the results presented in the previous
section, φ(t) departs from the point (0.15, 0.15) (i.e. the point corresponding to the initial levels
of expression of the acidity-resistant gene and the hypoxia-resistant gene across the whole tissue
region) and, for all values of ηo/ηl considered, ultimately converges to a point corresponding to a
high expression level of both the acidity-resistant gene and the hypoxia-resistant gene. However,
larger values of the ratio ηo/ηl lead the level of expression of the hypoxia-resistant gene ν2(t) to
increase faster than the level of expression of the acidity-resistant gene ν1(t), while smaller values
of ηo/ηl correlate with a faster increase of ν1(t) and a slower increase of ν2(t). Furthermore, for
intermediate values of the ratio ηo/ηl we observe a simultaneous increase of the values of ν1(t) and
ν2(t), whereas sufficiently large and sufficiently small values of ηo/ηl correlate with a decoupling
between the increase of ν1(t) and ν2(t). In more detail, if the ratio ηo/ηl is sufficiently high, first
ν2(t) increases while ν1(t) remains almost constant and then, when ν2(t) is sufficiently high, ν1(t)
starts increasing as well. On the other hand, in the case where ηo/ηl is sufficiently low, we have
that ν1(t) increases first and then ν2(t) starts increasing as soon as ν1(t) becomes sufficiently high.
These results communicate the biological notion that: the strength of the selective pressures
exerted by oxygen and lactate on tumour cells, which are quantified by the values of the selection
gradients ηo and ηl, may shape the emergence of hypoxic resistance and acidic resistance in tu-
mours; the order in which such forms of resistance develop depend on the intensity of oxygen-driven
selection in relation to the intensity of lactate-driven selection.
4 Conclusions and research perspectives
In this work, we have developed a mathematical modelling approach to investigate the influence
of hypoxia and acidity on the evolutionary dynamics of cancer cells in vascularised tumours.
The results of numerical simulations of a calibrated version of the model based on real data
recapitulate the eco-evolutionary spatial dynamics of tumour cells and their adaptation to hypoxic
and acidic microenvironments. In particular, the results obtained indicate that tumour cells char-
acterised by lower levels of expression of hypoxia- and acidity-resistant genes are to be expected to
colonise well-oxygenated and mildly-acidic regions of vascularised tissues, whereas cells expressing
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Figure 8: Plot of the curve φ(t) =
(
ν1(t), ν2(t)
)
for different values of the ratio between the selection gradient
related to oxygen ηo and the selection gradient related to lactate ηl. The functions ν1(t) and ν2(t) defined via (3)
model the levels of expression of the acidity-resistant gene and the hypoxia-resistant gene across the whole tissue
region, respectively.
a more aggressive phenotype characterised by higher levels of resistance to hypoxia and acidity
will ultimately populate tissue regions corresponding to hypoxic and acidic microenvironments.
Such theoretical findings recapitulate histological data on ductal carcinoma in situ showing that
the levels at which the acidity-resistant gene LAMP2 and the hypoxia-resistant gene GLUT-1
are expressed by cancer cells increase moving from the walls to the centre of the milk duct (i.e.
moving from more oxygenated and less acidic regions to regions that are less oxygenated and more
acidic) [19, 26].
Moreover, our theoretical findings reconcile the conclusions of [26], suggesting that tumour
cells acquire first resistance to hypoxia and then resistance to acidity, and the conclusions of [57],
supporting the idea that the two forms of resistance are acquired in reverse order, by showing that
the order in which resistance to hypoxia and resistance to acidity arise depend on the ways in
which oxygen and lactate act as environmental stressors in the evolutionary dynamics of tumour
cells, which are known to vary between tissue types and between patients [46].
We conclude with a brief overview of possible research perspectives. Along the lines of [43],
the modelling framework presented here could be extended to incorporate additional details of cell
movement and mechanical interactions between cells [2, 8, 12], which would make it possible to
investigate the interplay between phenotypic evolution of cancer cells and tumour growth.
Moreover, building on [7], it would be interesting to generalise the model to study the effects of
fluctuations in the inflow rate of oxygen and glucose and the outflow rate of lactate in the evolution
of cancer cells. In fact, when in hypoxic conditions, cancer cells are known to produce and secrete
proangiogenic factors which induce the formation of new blood vessels departing from existing ones.
Such an angiogenic process results in the formation of a disordered tumour vasculature whereby
the rates at which oxygen and glucose enter the tumour and the rate at which lactate is flushed
out through intra-tumour blood vessels fluctuate over time, which impacts on the evolutionary
dynamics of cancer cells [21, 35, 49, 51].
It would also be interesting to extend the model in order to investigate the role of pheno-
typic transitions triggered by hypoxia and acidity – such as the epithelial-mesenchymal transition
induced by hypoxic environmental conditions [53, 59, 65] and the acquisition of the metastatic
phenotype promoted by acidic microenvironments [19, 20, 22] – in the phenotypic adaptation of
cancer cells and tumour growth.
Finally, since resistance to hypoxia is known to correlate with resistance to chemotherapy
and radiotherapy [18, 20, 38, 56, 61], building on [15, 42, 44], it would be relevant for anti-
cancer therapy to address numerical optimal control for an extended version of the model that
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takes into account the effect of chemotherapy and/or radiotherapy [6, 55], which could inform
the development of optimised cancer treatment protocols that exploit evolutionary and ecological
principles [1, 27, 36, 50].
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